OTCMKTS:KHRNF Khiron Life Sciences (KHRNF) Stock Price, News & Analysis → my top trade on these 9 tickers (From DTI) (Ad) Free KHRNF Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range$0.0001▼$0.017552-Week Range N/AVolume7,300 shsAverage Volume177,427 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get Khiron Life Sciences alerts: Email Address Ad DTIBuy Friday, Sell Monday, No Exceptions Every week traders grind it out Monday through Friday… But neglect trading Friday to Monday… Or… “over the weekend” As one professional trader explains, trading over the weekend is one of the most forgiving strategies you can use today. It allows him to sidestep a lot of the midweek volatility. Yet, gives him the opportunity to target some of the markets biggest stock moves. Just recently, he posted a trade on Nordstrom… The trade was published at 3pm on a Friday afternoon and by Monday morning the trade more than doubled.And for the first time in 2024, he’s sharing his strategy for free. About Khiron Life Sciences Stock (OTCMKTS:KHRNF)Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.Read More Ad Behind the MarketsThe Small Biotech with a BIG Cancer SolutionThere's a new cancer treatment so precise, it's been called a "smart bomb." One that can deliver a toxic payload directly to tumors while bypassing healthy cells.Get the full story here >>> KHRNF Stock News HeadlinesFebruary 19, 2024 | finance.yahoo.comKhiron Life Sciences Corp. (KHRNF)January 3, 2024 | benzinga.comKhiron Life Sciences Stock (OTC:KHRNF) Dividends: History, Yield and DatesMarch 28, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.November 17, 2023 | finance.yahoo.comKhiron Life Sciences Announces Closing of the Sale of Its European BusinessOctober 8, 2023 | finance.yahoo.comKhiron Life Sciences Corp (4KH.BE)July 11, 2023 | msn.comCannabis Stock Gainers And Losers From July 11, 2023June 19, 2023 | sg.finance.yahoo.comKHRNF - Khiron Life Sciences Corp.June 5, 2023 | finanznachrichten.deKhiron Life Sciences Corp.: Khiron Life Sciences Agrees to $500,000 Secured DepositMarch 28, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.June 5, 2023 | finance.yahoo.comKhiron Life Sciences Agrees to $500,000 Secured DepositMay 6, 2023 | finance.yahoo.comKHIRON LIFE SCIENCES ANNOUNCES CEASE TRADE ORDERApril 20, 2023 | finance.yahoo.comKhiron Completes First Phase of Business OptimizationApril 17, 2023 | msn.comKhiron Life Sciences CFO Helen Bellwood to be replaced by Michael O'ConnorApril 17, 2023 | finance.yahoo.comKHIRON LIFE SCIENCES ANNOUNCES NEW CFOApril 17, 2023 | finance.yahoo.comTake Care Before Jumping Onto Khiron Life Sciences Corp. (CVE:KHRN) Even Though It's 47% CheaperApril 12, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp WT down on Monday (KHRN-WT)March 24, 2023 | benzinga.comKhiron Stock Trading Lower On Announcing Pricing Of Marketed Offering Of UnitsMarch 24, 2023 | finance.yahoo.comKHIRON LIFE SCIENCES ANNOUNCES PRICING OF MARKETED OFFERING OF UNITSMarch 16, 2023 | marketwatch.comKhiron Life Sciences Shares Drop 28% on Overnight OfferingFebruary 17, 2023 | seekingalpha.comKHRNF Khiron Life Sciences Corp.February 16, 2023 | finance.yahoo.comKhiron Closes Additional Loan with Investment-Grade BankFebruary 14, 2023 | finance.yahoo.comKhiron Closes Revolving Credit Facility with Financing Company in ColombiaJanuary 18, 2023 | proactiveinvestors.comKhiron Life Sciences shares growth in medical cannabis field throughout South America and EuropeJanuary 9, 2023 | finanznachrichten.deKhiron Life Sciences Corp.: Khiron wins first medical cannabis contract with Colombia's largest public insurance companyDecember 1, 2022 | finance.yahoo.comKhiron Life Sciences Third Quarter 2022 Earnings: CA$0.017 loss per share (vs CA$0.019 loss in 3Q 2021)November 30, 2022 | seekingalpha.comKhiron Life Sciences Corp. (KHRNF) Q3 2022 Earnings Call TranscriptNovember 30, 2022 | finanznachrichten.deKhiron Life Sciences Corp.: Khiron Life Sciences Reports Third Quarter 2022 Financial ResultsSee More Headlines Receive KHRNF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Khiron Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:KHRNF CUSIPN/A CIKN/A Webwww.khiron.ca Phone(702) 527-3564FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesDr. Alvaro Francisco Torres (Age 45)Co-Founder, CEO & Director Comp: $201.71kMs. Franziska KatterbachPresident of Khiron EuropeMr. Swapan Kakumanu ACA (Age 54)ACWA, CGA, Corporate Secretary Comp: $44.34kMr. Michael John O'Connor MA (Age 57)Chief Financial Officer Mr. Manuel BuendiaVice President of OperationsMr. Marco AlgortaCountry Manager of UruguayMore ExecutivesKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors KHRNF Stock Analysis - Frequently Asked Questions How do I buy shares of Khiron Life Sciences? Shares of KHRNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:KHRNF) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThe 3rd Revolution in WarfareWeiss RatingsBill Ackman’s 2024 warningPorter & CompanyUrgent: Protect Your Investments from a Chinese InvasionBehind the MarketsYou won't believe what Citigroup just did to it's depositorsAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Khiron Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.